UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 4, 2020
Accession Number:
0001477932-20-002199
Submission Type:
POS AM
CIK:
0001622057
Company Name:
Nascent Biotech Inc.
File Number:
333-233834